# Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

> **NCT02332356** · PHASE3 · UNKNOWN · sponsor: **Tokyo Medical and Dental University** · enrollment: 100 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** azathioprine or adalimumab and infliximab

## Key facts

- **NCT ID:** NCT02332356
- **Lead sponsor:** Tokyo Medical and Dental University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332356, "Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02332356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*